相关实验视频
Updated: Jun 16, 2026

08:49
Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
16.3K
在大肠炎模型中,大吉素对瘤愈合的影响
Başar Can Turgut1, Muge Yurdacan Sahin2, Ozan Akıncı3
1Department of General Surgery, Istanbul Traning and Research Hospital, Istanbul-Türkiye.
概括
豆类异黄Daidzein在老鼠中没有改善结肠瘤的愈合,即使存在大肠炎. 这项研究发现,当大吉素被施用时,对静脉愈合或氧化应激标志物没有任何益处.
科学领域:
- 胃肠病学 胃肠病学
- 手术研究的研究.
- 药理学 药理学是指药理学的学科.
背景情况:
- 研究大豆异黄中的一种 - - 戴兹的治疗潜力,以增强结肠瘤治疗.
- 利用小鼠实验性结肠炎模型来模拟影响手术修复的炎症状况.
研究的目的:
- 评价肠道注射大吉素对大鼠结肠瘤治疗的影响.
- 为了确定大吉素是否影响关键的治疗参数,如氧水平,静脉突破压力和氧化应激标志物.
主要方法:
- 48只雄性Wistar白色老鼠通过直肠乙酸给药或接受水来诱导大肠炎.
- 所有老鼠都通过手术创建了结肠瘤.
- 戴兹是口服给特定组的,在术后第3天和第7天进行了分析.
主要成果:
- 在有或没有大肠炎的老鼠中,肠道戴兹并没有积极影响门愈合,氧水平或突发压力.
- 戴兹未能降低氧化应激标志物,包括谷氨过氧化酶和超氧化物脱酶.
- 在晚期术后期,在非结肠炎组中,观察到戴兹对病理损伤得分产生轻微的有益影响.
结论:
- 在大肠炎或无大肠炎的条件下,戴兹的使用没有对结肠异位瘤愈合产生积极影响.
- 结果表明,在这个实验模型中,戴兹在促进结肠外科愈合方面没有效果.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

